Sequana Medical NVSTU:2SE 34 Pretax Margin % is % as of Jun. 2025. GuruFocus rates STU:2SE with a GF Score™ of 34/100 and a GF Value™ of €0.19 (Significantly Overvalued). The stock has 12 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Sequana Medical NV ranks worse than 99.51% on this metric.
The historical rank and industry rank for Sequana Medical NV's Pretax Margin % or its related term are showing as below:
STU:2SE'
s Pretax Margin % Range Over the Past 10 Years
Min: -41861.32 Med: -1748.07 Max: -629.37
Current: -41861.32
STU:2SE's Pretax Margin % is ranked worse than 99.51% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 2.505
vs STU:2SE: -41861.32
Sequana Medical NV (STU:2SE) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Sequana Medical NV Pretax Margin % Related Terms
Sequana Medical NV Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Sequana Medical NV's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:2SE vs ABT, SYK, MDT: Pretax Margin % Comparison
For the Medical Devices subindustry, Sequana Medical NV's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sequana Medical NV Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sequana Medical NV's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Sequana Medical NV's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sequana Medical NV (STU:2SE) has a Pretax Margin % of % as of Jun. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Sequana Medical NV and its competitors. According to the industry distribution chart, Sequana Medical NV ranks #812 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 99.5%.
Is Sequana Medical NV's Pretax Margin % too high?
Sequana Medical NV's current Pretax Margin % is %. Based on the distribution chart, Sequana Medical NV ranks #812 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sequana Medical NV has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sequana Medical NV's Pretax Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sequana Medical NV ranks #812 out of 816 companies for Pretax Margin %. This places Sequana Medical NV in the lower half of its industry. The industry median Pretax Margin % is 2.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.51, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Sequana Medical NV and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sequana Medical NV's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sequana Medical NV stock overvalued right now?
Based on GuruFocus' analysis, Sequana Medical NV (STU:2SE) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.19, compared to a current price of €0.51 — trading 168.9% above its estimated fair value. The current Pretax Margin % is %. Sequana Medical NV's overall GF Score™ is 34/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Sequana Medical NV (STU:2SE), the current Pretax Margin % is % as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sequana Medical NV (STU:2SE) Overvalued in 2026?
Based on GuruFocus' analysis, Sequana Medical NV stock appears to be overvalued.
The current stock price of €0.51 is trading 168.9% above its estimated GF Value™ of €0.19.
GuruFocus considers Sequana Medical NV to be Significantly Overvalued.
Key valuation signals for STU:2SE:
Pretax Margin %: %
GF Value™: €0.19 vs. price of €0.51 (168.9% above fair value)
No single metric tells the full story. See the STU:2SE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies. The company's geographical segments include Switzerland, Germany, the United Kingdom, France, and the Rest of the world, out of which Germany accounts for the majority of the revenue.
34GF Score
Get the complete analysis for STU:2SE
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:2SE has been successfully added to your 
